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Heterogeneity is an inherent feature of the glycosylation process. Mammalian cells
often produce a variety of glycan structures on separate molecules of the same
protein, known as glycoforms. This heterogeneity is not random but is controlled by the
organization of the glycosylation machinery in the Golgi cisternae. In this work, we use
a computational model of the N-glycosylation process to probe how the organization of
the glycosylation machinery into different cisternae drives N-glycan biosynthesis toward
differing degrees of heterogeneity. Using this model, we demonstrate the N-glycosylation
potential and limits of the mammalian Golgi apparatus, for example how the number of
cisternae limits the goal of achieving near homogeneity for N-glycans. The production
of specific glycoforms guided by this computational study could pave the way for
“glycoform engineering,” which will find uses in the functional investigation of glycans,
the modulation of glycan-mediated physiological functions, and in biotechnology.
Keywords: computational modeling, Golgi apparatus, glycan biosynthesis, cisternal number, glycan
heterogeneity
INTRODUCTION
N-glycosylation is a process initiated in the endoplasmic reticulum (ER) but specific structural
elements such as core fucosylation and branching (Figure 1A) are introduced later in the
secretory pathway in the Golgi apparatus. N-glycans are modified by a series of sequentially
acting glycosidases and glycosyltransferases (Figure 1B) that modify glycans in the Golgi apparatus
and consequently dictate and ultimately determine the glycan profile of the whole cell. However,
the structural modification of N-linked glycans is a complex process that results in numerous
different glycan structures. In the absence of a “glycan template,” protein glycosylation is inherently
heterogenous with a number of factors contributing to the final glycan structure. These variables
include the protein structure (Hang et al., 2015; Suga et al., 2018), secretory protein load (Jimenez-
Mallebrera et al., 2009), Golgi transport mechanism (Hossler et al., 2007), enzyme protein levels,
availability of monosaccharide-nucleotides, and the organization of glycosylation enzymes within
the Golgi apparatus (Oka et al., 2004; Zolov and Lupashin, 2005; Fisher andUngar, 2016). Typically,
N-glycan biosynthesis can be characterized as a series of divergent pathways that converge into
structural nodes (Figure 1B). Following the initial trimming of mannoses by ManI, the number
of possible N-glycan structures generated in the Golgi apparatus increases exponentially with each
additional monosaccharide until the capping of antennae with sialic acid (Spahn et al., 2016).
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N-glycans can play important roles in dictating the properties
of glycoproteins. From a biologic’s standpoint, controlling
the glycans residing on therapeutic antibodies can tune
their pharmaceutical properties. For example, glycans lacking
core fucose (Figure 1A) can increase antibody-dependent
cellular cytotoxicity (ADCC) (Shinkawa et al., 2003; Yamane-
Ohnuki et al., 2004). Overall it appears that fucosylation
and galactosylation are the dominant features of N-glycans
that influence Fc-receptor binding (Dekkers et al., 2017),
which is linked to ADCC. Furthermore, the presence of
sialylated complex type glycans increases the in vivo half-
life of therapeutic antibodies compared to oligomannose type
glycans (Kanda et al., 2007) further illustrating the attenuating
role of N-glycans in IgG properties. Due to the heterogenous
nature of glycan biosynthesis the production of homogenous
biologics with respect to glycosylation is currently not feasible,
giving rise to batch-to-batch variation, and heterogeneity
within batches. Glyco-engineering of biologics, for example
through the deletion of Mgat1 to eliminate complex and
hybrid glycans from CHO cells, reduces glycan heterogeneity,
and improves immunological properties (Xu et al., 2016).
However, eliminating complex glycans also removes any
ability to fine-tune the properties of a therapeutic through
presence/absence of other N-glycan features such as those
shown in Figure 1A. Therefore, devising novel strategies
to reduce glycan heterogeneity and/or enrich the relative
abundance of a desired glycan is of great value to the
pharmaceutical industry.
Glycosylation enzyme levels play a pivotal role in glycan
biosynthesis; however, the outcome of enzyme depletion
or overexpression can be unexpected. Knockdown of the
galactosyltransferase GalT4 alongside overexpression of the
branching enzymes Mgat4 and/or 5 in CHO cells substantially
increased the abundance of tri- and tetra-antennary N-glycans.
Interestingly though, it was the reduction of GalT4 that primarily
accounted for the increase in branching (McDonald et al.,
2014). Two additional important factors in determining the
N-glycans produced by mammalian cells are the distribution
of the glycosylation enzymes within the Golgi apparatus
(Fisher and Ungar, 2016), and the architecture of the Golgi
apparatus itself. For example, disruptions to the conserved
oligomeric Golgi (COG) complex, which is involved in
tethering and thereby targeting intra-Golgi retrograde
vesicles, can lead to glycosylation defects in model cell lines
(Shestakova et al., 2006; Bailey Blackburn et al., 2016) and
to congenital disorders of glycosylation (reviewed in Wu
et al., 2004; Steet and Kornfeld, 2006; Hennet and Cabalzar,
2015). Furthermore, the depletion of the Golgi reassembly
stacking proteins (GRASPs) of 55 and 65 kDa results in
an acceleration of protein transport, Golgi fragmentation,
and impaired glycosylation (Xiang et al., 2013; Bekier et al.,
2017). Fragmentation of the Golgi apparatus has also been
linked to numerous neurodegenerative disorders (reviewed
in Joshi et al., 2015). Alterations to the architecture and the
organization of the Golgi apparatus provide a potential route
to controlling glycosylation alongside the protein levels of
the glycosylation machinery themselves. Other factors such
as the availability of the monosaccharide-nucleotide donors
are important and worthy of further investigation but are not
considered in this work.
In this work we build on previous studies of glycosylation
in WT HEK293T cells (Bailey Blackburn et al., 2016) and a
stochastic model of N-glycosylation we recently developed and
validated (Fisher et al., 2019).We used this model of glycosylation
to demonstrate in silico the effects of cisternal number on glycan
heterogeneity and complexity. This led us to test computationally
what limitations the existing Golgi apparatus architecture places
on the degree of glycan homogeneity achievable in mammalian
cells. Finally, we used our model to predict strategies to increase
the relative abundance of targeted glycan structures.
RESULTS AND DISCUSSION
It is not the aim of this work to describe in great detail
the modeling methodology that has been used (for a more
detailed description on the development and validation of
the modeling framework used in this work please see Fisher
et al., 2019), however, a brief summary of the modeling
methodology will give context and a greater understanding
of the results of this work. Glycosylation reactions are
simulated using a stochastic simulation algorithm (SSA).
The SSA incorporates the inherent noise that is present
in biological systems and that becomes increasingly relevant
when the number of reactants (and enzymes) are small, as
is the case for glycosylation in the Golgi. In contrast to
models of glycosylation based on ordinary differential equations
(ODEs) (Hossler et al., 2007; Krambeck et al., 2009, 2017;
Goey et al., 2018), several factors can be included in each
parameter, reducing the need for excessive parameterization in
our model. As such, we define parameters for each enzyme
by using the term “effective enzymatic rate” to encompass
the enzyme’s protein level, availability of its nucleotide-
monosaccharide substrates and the chemical enzymatic rate.
In this work we do not wish to consider changes to
intrinsic enzymatic properties such as the inherent chemical
enzymatic rate constants, therefore any predicted alterations
to the effective enzymatic rate parameter are assumed to
be equivalent to alterations in the protein level of the
respective enzyme.
The effective enzymatic rates, the transit time in the
Golgi apparatus, and the composition of glycans entering
the Golgi were the parameters that were altered to fit the
computed to a target glycan profile. This fitting was done
using an approximate Bayesian computation (ABC) algorithm
(Marjoram et al., 2003), which samples from parameter
distributions to feed the SSA and assess the goodness of fit
with a target profile. The shift of the parameter distributions
during fitting tells us how the organization (e.g., levels and
localizations) of enzymes changes from the starting condition
to reach the target glycan profile. We utilize the optimized
parameters determined previously for the WT HEK293T
cell glycan profile as initial values (Fisher et al., 2019),
therefore predicted changes in effective enzymatic rates are
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FIGURE 1 | N-glycan processing pathways to generate a fully sialylated bi-antennary glycan. (A) Pictorial examples of structural features of complex N-glycans that
are referred to in this work. (B) N-glycan biosynthesis pathway for Fuc1GlcNAc4Man3Gal2NeuAc2 starting with the two oligomannose glycans that enter the Golgi
apparatus. The biosynthesis of complex N-glycans is characterized by increasing numbers of reaction paths that ultimately converge on structural nodes often due
to the addition of terminating sialic acids.
relative to the organization of the glycosylation machinery in
WT HEK293T cells.
Glycan Heterogeneity and the Golgi
Apparatus
We set out to evaluate how the level of glycan heterogeneity is
affected by different variables in our model of N-glycosylation.
An important variable is the number of cisternal elements,
which is known to vary between species, cell types (Mironov
et al., 2017), and in pathologies (Joshi et al., 2014). In our
earlier work four cisternae were found to be required to
optimally model HEK293T cell N-glycans (Fisher et al., 2019).
While this number does not necessarily reflect the actual
number of cisternae in this cell type, deviations from this
number during modeling reflect potential changes in cisternal
number. In order to investigate the effect of architecture on
the glycan processing potential of the Golgi apparatus, the
number of cisternal elements in our stochastic model of the
Golgi was varied from the four required for HEK293T cells
in previous work (Fisher et al., 2019). The total effective
rate for each enzyme was kept constant, as was the total
time spent in the Golgi apparatus. As a measure of glycan
heterogeneity in these simulations, the number of different
glycan structures produced in the simulation was recorded
(Figure 2A). The trend is of decreasing heterogeneity as the
number of cisternal elements is increased from two to ten. In
addition to the observed decrease in heterogeneity correlating
with increasing cisternal elements, the relative abundance of
oligomannose glycans also increases as the trimming of mannose
residues becomes less efficient possibly due to the reduced
time per cisterna. The reduction in glycan maturity observed
in GRASP55/65 double knockout (KO) cells may therefore
be a consequence of the fragmented Golgi apparatus (Bekier
et al., 2017). Interestingly, by changing the number of cisternal
elements the most abundant complex glycans simulated by our
model also differed (Figure 2C). For example, and in support
of the hypothesis that the organization of a fragmented Golgi
apparatus may explain the reduction in glycan maturity in
GRASP55/65 KO cells, simulations with more than four cisternal
elements generated immature complex glycans in comparison
to simulations involving one and two cisternal elements, which
generated higher relative abundances of more elaborate glycans
containing more antennae, and a higher proportion of sialic acids
(Figure 2C). This is possibly a knock-on effect of the reduced
efficiency of oligomannose processing as mentioned above, and
could possibly be explained with the shorter processing time in
each individual cisterna.
In the previous simulation, the total time taken to traverse
the Golgi apparatus was kept constant while the number
of cisternal elements was altered. Next, we were interested
in what effect varying the transit time per cisterna had
on glycan heterogeneity and complexity while keeping the
number of cisternae at four. Indeed, altering the time taken
to traverse the Golgi apparatus had a different effect than
varying the number of cisternal elements (Figure 2B). The
number of different glycan structures predicted when the time
was reduced to 10% of the WT time decreased dramatically
(Figure 2B). Following a gradual increase and plateauing of
glycan heterogeneity with increasing time in the Golgi apparatus,
the number of glycan structures begins to decrease again at
250% of WT time. This is due to glycan pathways converging
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FIGURE 2 | Effect of cisternal number and transit time on glycan heterogeneity. (A) Total number of glycans (circles) and proportion of oligomannose glycans (bars)
produced in silico when starting with parameters fitted for the WT HEK293T cell glycan profile altering the number of cisternal elements (CS) in the system from the
four (striped bar) used in the WT HEK293T model. The distribution of enzymes across the model Golgi apparatus, the total effective rates for each enzyme and the
total time spent in the Golgi apparatus was kept the same for each simulation. (B) As in “A” but varying the total time spent in the Golgi with four cisternae. Striped
bar indicates transit time for the WT HEK293T cell model; the times shown for all other simulations are relative to this value. (C) Relative proportions of the three
most abundant complex glycans predicted by the model Golgi apparatus when the number of cisternal elements are altered. For all simulations error bars show
standard deviation for n = 3.
on structural nodes with terminating sialic acids. For example,
the abundance of the fully sialylated bi-antennary glycan,
Fuc1GlcNAc4Man3Gal2NeuAc2, increases from 4.5% to close
to 10% of the total when the transit time is increased 3.3-
fold of that of WT. In contrast, this same glycan is absent
from the simulated profile when the transit time is reduced
10-fold compared to WT.
Interestingly, GRASP55/65 depletion accelerates protein
trafficking through the Golgi apparatus (Xiang et al., 2013;
Bekier et al., 2017), an effect that our model would predict
to decrease the relative abundance of complex N-glycans
(Figure 2B). Indeed, published experimental evidence shows
less processing for both cell surface and intracellular glycans
in these cells (Bekier et al., 2017). In contrast, there was
a minor kinetic delay for the delivery of VSV-G to the
plasma membrane in Cog3 knockdown HeLa cells (Zolov
and Lupashin, 2005), indicating a reduced rate of anterograde
transport. This is unlikely to be the direct cause of the
glycosylation defect though, as Cog3 depletion results in
relocation and partial degradation of Golgi glycosylation
enzymes (Shestakova et al., 2006), as opposed to GRASP55/65
depletion that had no effect on the localization and levels
of the glycosylation enzymes studied (Xiang et al., 2013).
Furthermore, our model suggests slower transport through the
Golgi apparatus would reduce the oligomannose content, a
feature that is not observed in COG subunit depleted cell lines
(Bailey Blackburn et al., 2016).
Maximizing the Relative Abundance of
Target Glycans
The production of single glycoforms is an important goal in
the pharmaceutical industry. We therefore used our modeling
framework to assess the glycan processing potential of the Golgi
apparatus. In this instance, we tested the potential of the Golgi
apparatus to produce a single glycoform, within reasonable
biological boundaries. Three complex glycans with partial or
complete sialylation and two or three antennae (Table 1) were
chosen to test this property of the Golgi apparatus. The three
complex glycans are referred to as bi-Sia1, bi-Sia2, and tri-Sia1
when they are described as the target for glycan engineering.
When the same structures appear in the simulation as by-
products though, they are referred to in conventional glycan
notation. Starting with the fitted parameters for the effective
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TABLE 1 | Target glycans.
Glycan
structure
Abbreviation % of target glycan
observed in WT
HEK293T glycan
profile
% of target
glycan using
variable
localization
fitting
% of target
glycan using
fixed localization
fitting
Bi-Sia1
(Fuc1GlcNAc4
Man3Gal2
NeuAc1)
13.5 70.7 74.6
Bi-Sia2
(Fuc1GlcNAc4
Man3Gal2
NeuAc2)
4.5 96.3 97.9
Tri-Sia1
(Fuc1GlcNAc5
Man3Gal3
NeuAc1)
2.9 66.9 63.8
enzymatic rates for WT HEK293T cells, we used ABC fitting
to maximize the relative abundance of each target glycan. For
this purpose, a hypothetical glycan profile was fitted in which
100% of the complex glycan was set as the desired N-glycan. The
parameters that were fitted for these experiments were: effective
enzymatic rates, transit time per cisterna and composition of
glycans entering the Golgi. In addition, we investigated the
maximization of target glycans in two scenarios: One, in which
the distribution of enzymes between Golgi cisternae can be varied
(variable localization); and another one, in which the distribution
of enzymes in the Golgi apparatus is fixed to that observed inWT
cells (fixed localization).
Table 1 shows the percentage of the target glycan normalized
to the total amount of complex glycan observed experimentally
in WT HEK293T cell samples (Bailey Blackburn et al., 2016).
For all of the target glycans the proportion could be increased
above that found in WT HEK293T cells (Table 1). Bi-Sia2 could
be produced by the simulation at the highest relative abundance
due to the terminating sialic acids on both antennae, which are
endpoint structures. In contrast, homogeneous production of
partially sialylated glycans is predicted to be much more difficult
if not impossible to achieve according to our stochastic model.
When comparing the fits to the bi-Sia1 and tri-Sia1 targets we
can also say that adding a third antenna makes the drive to
homogeneity again more difficult, implying that the inclusion of
tri- and/or tetra-antennary glycans in products will inadvertently
increase heterogeneity, as was observed in glycan-engineered
plant expression systems (Nagels et al., 2012).
As expected, the most abundant glycan by-products predicted
when maximizing the production of each target glycan were
quite different (Figure 3). When maximizing the abundance
of bi-Sia1, the major by-products were the un-sialylated bi-
antennary glycan Fuc1GlcNAc4Man3Gal2 and the fully sialylated
Fuc1GlcNAc4Man3Gal2NeuAc2. This result suggests a small
window in which the glycoprotein must exit the Golgi
apparatus following the initial sialylation but prior to the
second sialylation reaction to achieve a bi-Sia1 glycan structure.
The result is similar when enriching tri-Sia1, as the dominant
predicted by-products are the over-sialylated tri-antennary
glycan, Fuc1GlcNAc5Man3Gal3NeuAc2, and the under sialylated
tri-antennary glycan, Fuc1GlcNAc5Man3Gal3 (Figure 3). The
major by-products for bi-Sia2 were the fully sialylated tri-
antennary glycan, Fuc1GlcNAc5Man3Gal3NeuAc3 suggesting
that the modeled sialyation activity is not limiting the production
of bi-Sia2, rather the presence of branching enzymes is diverting
flux away from bi-Sia2. These by-products could of course be
eliminated by modeling a cell line in which the branching
enzymes are completely removed, but the ABC algorithm has
difficulties pushing enzyme levels to complete elimination i.e.,
zero, as it will always sample from a non-zero distribution.
Having started with the WT HEK293T cell parameters (Fisher
et al., 2019), relative changes in enzyme distributions between
Golgi cisternae that maximize the target glycans in silico can be
predicted when using localization dependent fitting (Figure 4).
For all target glycans an increase in the Mgat1 effective enzymatic
rate within the second cisterna is required, and a similar change
is seen for Fut8 (Figure 4). Both of these enzymes act early
in the generation of complex N-glycans (Calderon et al., 2016;
Fisher et al., 2019). The increases in their levels in an early
cisterna presumably ensures that glycan processing can proceed
more completely toward the desired products without the
accumulation of partially processed intermediates. For the two bi-
antennary glycan targets Mgat2 was required to be redistributed
toward the trans side of the Golgi apparatus relative to the
simulated WT distribution (Figure 4). Analysis of the flux map
revealed that the shift in Mgat2 toward the trans side of the
Golgi apparatus changed the dominant substrates for Mgat2
(Figure 5A). For the model of WT N-glycosylation only ∼8%
of the Mgat2 substrates were fucosylated. In contrast, more than
60% of the Mgat2 substrates were fucosylated in the model
primed to maximize the abundance of bi-Sia1, and a similar
shift in substrate preference is seen for bi-Sia2 (Figure 5B).
Unsurprisingly, the effective enzymatic rate of the branching
enzyme Mgat5 was predicted to be increased when trying to
maximize the abundance of tri-Sia1; however, the distribution of
Mgat5 was also required to shift more to the trans side of the
Golgi apparatus (Figure 4). This shift in Mgat5 coincided with
an equivalent shift of GalT into the trans-Golgi, a characteristic
that aims to spatially separate the two enzymes within the
Golgi apparatus (Figure 4). This is in line with competition
between galactosylation and glycan branching, a feature that
was suggested to explain the demonstrated role of GalT in
determining and controlling antenna number (McDonald et al.,
2014; Fisher et al., 2019).
If we assume that the intrinsic rates of the glycosylation
enzymes are not altered, predicted changes to the effective rates
that are made by our model can be rationalized as overexpression
or knock down of the relevant protein levels. Such an approach
to reducing glycan heterogeneity and enriching the target glycan
has indeed been previously applied experimentally for the simple
case of core fucosylation (Yamane-Ohnuki et al., 2004). Figure 6
shows the predicted changes in total effective rate for each
enzyme necessary to maximize the relevant target glycan. The
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FIGURE 3 | Glycan by-products of maximizing target complex glycans. Relative abundance of the oligomannose pool and the three most abundant complex
glycans that are predicted as by-products when maximising the abundance of the indicated target glycans with the indicated type (fixed or variable enzyme
localization) of fitting strategy.
FIGURE 4 | Optimized Golgi distribution of enzymes to maximize the relative abundance of target glycans. Distributions of the effective enzymatic rates for the
indicated enzymes throughout the Golgi apparatus following fitting with variable enzyme localization to maximize the abundance of the indicated target glycans. The
predicted distribution in WT HEK293T cells (Fisher et al., 2019) is shown for comparison.
differences in total effective enzymatic rates between the fits
using variable and fixed enzyme localizations suggest that the
distribution of enzymes is an important factor to be considered
when designing genetic manipulations of the glycosylation
machinery. When the localization of enzymes is fixed, predicted
alterations to the total enzymatic rates are much larger than
those required in the variable localization scenario (Figure 6). For
example, the increase required for Mgat5 is more than threefold
higher for the fixed localization fitting of tri-Sia1 compared with
the variable localization fitting of the same glycan. While simply
altering the levels of enzymes could conceptually bemuch simpler
through knock-down or overexpression, their distribution may
also be changed through engineering of the intra-Golgi vesicular
sorting pathway. For example, manipulation of the interactions
of the COG vesicle tethering complex (Miller et al., 2013; Willett
et al., 2013), or adjustments in the cytosolic and transmembrane
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FIGURE 5 | Flux analysis of Mgat2 substrates in WT, bi-Sia1, and bi-Sia2 simulations. (A) Proportion of biosynthetic flux carried by Mgat2 from its three dominant
substrates in WT HEK293T cells (red) and the simulated profiles maximizing bi-Sia1 (blue) and bi-Sia2 (purple) fitted with variable enzyme localization. (B) The
proportion of substrates for Mgat2 that are fucosylated for the simulations described in “A.”
FIGURE 6 | Total enzymatic rate changes to maximize relative abundance of target glycans. Percentage changes in total effective enzymatic rates following fitting to
maximize the abundance of bi-Sia1 (blue), bi-Sia2 (red), and tri-Sia1 (green) fitted with variable enzyme localization (solid) and fixed enzyme localization (striped)
relative to the parameters predicted for the WT HEK293T cell profile. Total effective enzymatic rates obtained from the different fits were adjusted to ensure that the
transit time in each case matched that of the WT HEK293T simulation.
domains of particular glycosylation enzymes could both be used
to alter enzyme locations (Ferrara et al., 2006; Becker et al., 2018).
A Computationally Informed Strategy for
Producing Tetra-Antennary Glycans
Our ABC fitting strategy was unable to generate parameter
values for the effective enzymatic rates that would simulate the
production of significant amounts of tetra-antennary glycans.
Initial parameter values for this fitting were those of the WT
HEK293T cell line and therefore the huge shifts required in
the effective rate of Mgat4 and 5 are almost never accepted
within the fitting as they are considered highly unlikely relative
to the WT values. However, it was possible to devise strategies to
increase the output of tetra-antennary glycans from our model
(Figure 7A). Manually elevating the effective rates of Mgat4/5
10-fold, while keeping the distribution of the enzymes the same
as in WT HEK293T cells, increased the relative abundance
of tetra-antennary glycans about sevenfold, to roughly 25%
(Figure 7A). However, increasing the effective rates of Mgat4/5
further (100-fold) did not increase the relative abundance of
tetra-antennary glycans above that of the 10-fold increased
rates, but did increase the abundance of bi-antennary glycans
(not shown). In order to investigate why further increasing
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FIGURE 7 | Hypothetical engineering of the Golgi apparatus to increase the abundance of tetra-antennary glycans. (A) The relative abundance of all tetra- and
tri-antennary glycans produced in silico using effective enzymatic rates for: WT HEK293T (red), WT with the total effective enzymatic rates of Mgat4/5 increased
10-fold (dark blue), WT with the total effective enzymatic rates of Mgat4/5 increased 100-fold (light blue), WT with the distribution of enzymes in the model Golgi
apparatus set to separate Mgat4/5 from GalT (yellow), and WT with the total effective enzymatic rates of Mgat4/5 increased 10-fold and the localization of enzymes
in the model Golgi apparatus set to separate Mgat4/5 from GalT (yellow and dark blue striped). (B) Flux diagrams for selected N-glycosylation reactions for WT
HEK293T, WT with the total effective enzymatic rates of Mgat4/5 increased 10-fold and WT with the total effective enzymatic rates of Mgat4/5 increased 100-fold.
(C) Schematic showing the levels and relative localizations of key enzymes for WT HEK293T cells and the computationally engineered scenario predicted to
maximize the production of tetra-antennary glycans.
the effective enzymatic rates of Mgat4/5 did not result in a
concomitant increase in tetra-antennary glycans we examined the
flux diagrams for the three conditions (Figure 7B). Flux analysis
revealed that as the effective enzymatic rate of Mgat4 increases it
begins to outcompete ManII and Mgat2 in the earlier cisternae
resulting in a reduction in flux toward GlcNAc4Man3, which is
an important intermediate on the path of tetra-antennary glycan
biosynthesis (Figure 7B).
The enzymatic competition between ManII/Mgat2 and Mgat4
is predicted to limit the production of tetra-antennary glycans
alongside the known effect of GalT on controlling the degree
of N-glycan branching (Fisher et al., 2019). Elimination of
GalT was suggested as an approach to producing a larger
proportion of tetra-antennary glycans (McDonald et al., 2014).
Spatially separating Mgat4/5 from GalT in the Golgi apparatus
and therefore minimizing competition between the enzymes
(Figure 7C) could achieve a similar effect for increasing the
relative abundance of tetra-antennary glycans (Figure 7A).
Indeed, the spatial separation of Mgat5 and GalT that is enforced
by the model while enriching tri-Sia1 (Figure 4) demonstrates
that cisternal separation allows GalT to evade dominating Mgat5.
When applied to the task of increasing the proportion of
tetra-antennary glycans the effect was not as large as increasing
the effective rates of Mgat4/5, however, the two strategies were
synergistic (Figure 7A). It is important to note that separation of
the competing enzymes increased the relative abundance of tetra-
antennary glycans but these were often not sialylated. Therefore,
in this engineered theoretical scenario an additional cisterna
to accommodate sialylation reactions may also be required
depending on the target glycan.
CONCLUSION
In this work our computational model of mammalian
N-glycosylation has been used to probe the glycan processing
potential of the Golgi apparatus. While this study was based
on computation only, our model’s predictions generate some
testable hypothesis, which will be interesting to follow up on
using laboratory based experiments. Two aspects of Golgi
biology, which are commonly affected in pathologies such
as CDGs and neurological disorders, the architecture of the
Golgi apparatus and transit time through the Golgi apparatus
have been shown to be key determinants of the cellular glycan
profile. Golgi architecture and transit time should be considered
as important factors in glycosylation disorders that likely
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have an additive effect in disrupting the protein levels of the
glycosylation enzymes.
The goal of generating homogeneous glycoforms of biologics
from a process that is inherently heterogeneous is a difficult one.
Our model suggests several strategies that we predict will enrich
particular target glycan structures; however, our model could
not achieve complete homogeneity of glycoforms, suggesting
that full uniformity may not be achievable. In the cases of bi-
Sia1 and tri-Sia1 a higher percentage of the target glycan could
be achieved if the substrate specificities of the enzymes were
treated as a variable and not fixed. This suggests that when partial
sialylation (or galactosylation) is required, protein engineering
to adjust the substrate specificities of enzymes is a necessary
strategy. A combination of engineering glycosylation enzymes’
specificities, controlling effective enzymatic rates and organizing
the Golgi apparatus may all be required to attain higher
glycan homogeneity, but ultimately the number of cisternae
in a mammalian Golgi will likely be a key limiting factor for
producing large complex glycans close to homogeneity.
MATERIALS AND METHODS
Modeling Framework
The fitted and validated model of HEK293T cells (Fisher et al.,
2019) has been used extensively in this work. This model was
presented in detail in Fisher et al. (2019); it is generated using
a SSA based on the Gillespie algorithm (Doob, 1945; Gillespie,
1976) that was used to implicitly simulate enzyme competition
in the Golgi apparatus. Glycans entered the in silico Golgi
apparatus one at a time, hence our model does not account
for substrate competition or the potential effects of protein
load in the secretory pathway. The processing of 10,000 glycans
was simulated in order to generate a simulated glycan profile
from which the abundance of individual or structural classes
of glycans can be obtained. This profile is compared to a real
data set utilizing a Bayesian fitting methodology with priors
based upon biological knowledge. In the case of this study the
priors were based on the parameters obtained by fitting the WT
HEK293T glycan profile.
Transit Time and Cisternal Element
Number
The enzymatic parameters as well as the proportions of
Man9GlcNAc2, Man8GlcNAc2, and GlcMan9GlcNAc2 obtained
for the fitted WT HEK293T cell line (Fisher et al., 2019) were
used. The relative time taken for a glycan to transit through
each cisternal element was varied and the glycosylation reactions
simulated. The number of simulated glycans and the relative
abundance of oligomannose glycans was calculated from the
average of three simulations for each transit time.
For investigating the effect of cisternal element number on
the N-glycosylation process the total effective enzymatic rates
for each enzyme were kept constant in addition to the total
transit time and proportions of Man9GlcNAc2, Man8GlcNAc2,
and GlcMan9GlcNAc2. Extra cisternal elements were added by
calculating the average effective enzymatic rate between two
TABLE 2 | Distribution of Mgat2, Mgat4, Mgat5, and GalT in an engineered Golgi
apparatus to maximize tetra-antennary glycans.
Enzyme % effective
enzymatic rate
in 1st cisterna
% effective
enzymatic rate
in 2nd cisterna
% effective
enzymatic rate
in 3rd cisterna
% effective
enzymatic rate
in 4th cisterna
Mgat2 0 100 0 0
Mgat4 0 0 100 0
Mgat5 0 0 100 0
GalT 0 0 0 100
adjacent cisternae and then rescaling the effective enzymatic rates
to equal the total for the fitted WT HEK293T cells. By using this
strategy, we ensure any alterations to the simulated glycan profile
are not the result of changes in enzyme levels. The number of
simulated glycans and the relative abundance of oligomannose
glycans was calculated from the average of three simulations for
each cisternal number.
Maximizing Target Glycans
To predict alterations to enzyme levels and localization that
can maximize a given target glycan we used the ABC fitting
methodology to fit a simulated glycan profile to a hypothetical
observed glycan profile. The hypothetical glycan profile was
constructed bymaking the relative abundance of the target glycan
to 100% of the combined complex and hybrid glycan abundances.
The proportion of oligomannose glycans was kept at the level
observed in WT HEK293T cells in all target profiles. ABC
fitting methodology was then used to predict alterations in the
organization of the Golgi machinery to generate the hypothetical
glycan profile. The model was not penalized for what type of by-
products were produced, as such it is reasonable to assume that
the predicted by-products would be observed in a true glycan
profile of an engineered cell line.
Maximising Tetra-Antennary Glycans
WT HEK293T fitted parameters were used as a starting point.
The effective enzymatic rates of Mgat4 and Mgat5 were increased
10- or 100-fold and the glycan profile simulated. For the spatial
separation of the key enzymes involved in determining tetra-
antennary glycans, the effective enzymatic rates were condensed
into specific cisternae as shown in Table 2. The relative
abundance of all tetra-antennary glycans was calculated from the
average of three simulations for each different scenario.
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